Gsk【GSK】銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

1,305.00

買値

1,304.50

売値

1,305.50

出来高

298,969

1,300.00 日の範囲 1,309.50

1,282.50 52 週間の範囲 1,820.00

時価総額

54.093B

前日終値

1,300.00

始値

1,300.00

時刻

120

1305

(AT)

最終取引時間

17:58:34

財務取引量

3,900,397p

VWAP

1,304.6159

平均取引量 (3 か月)

8,420,977

発行済株式数

4,145,087,815

配当利回り

4.60%

PER

11.01

1 株当たり利益 (EPS)

1.19

歳入

30.33B

純利益

4.93B

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.gsk.com

本社

London, Gbr

設立

Gsk Plc is listed in the Pharmaceutical Preparations sector of the ロンドン証券取引所 with ticker GSK. The last closing price for Gsk was 1,300p. Over the last year, Gsk shares have traded in a share price range of 1,282.50p to 1,820.00p.

Gsk currently has 4,145,087,815 shares in issue. The market capitalisation of Gsk is £53.89 billion. Gsk has a price to earnings ratio (PE ratio) of 11.01.

GSK PLC Director/PDMR Shareholding

GSK PLC 19 November 2024 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Dr Hal Barron b) Position/status...

GSK hails positive results for linerixibat in treating relentless itch

GSK PLC on Tuesday said that its investigational targeted inhibitor linerixibat demonstrated sound results for a trea ...

GSK PLC GLISTEN Trial of Linerixibat Meets Endpoint

GSK PLC 19 November 2024 Issued: 19 November 2024, London UK Linerixibat shows positive Phase III results in cholestatic pruritus (relentless itch) in primary biliary cholangitis (PBC...

GSK hails survival results in blood cancer patients with Blenrep

GSK PLC on Thursday said its Blenrep drug has shown overall survival benefits in patients with relapsed or refractory ...

GSK PLC GSK announces overall survival results for Blenrep

GSK PLC 14 November 2024 Issued: 14 November 2024, London UK Blenrep shows overall survival benefit in head-to-head DREAMM-7 phase III trial for relapsed/refractory multiple myeloma · ...

GSK PLC Block listing Interim Review

GSK PLC 13 November 2024 BLOCK LISTING SIX MONTHLY RETURN Date: 13 November 2024 Name of applicant: GSK plc Name of scheme: GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan...

GSK PLC Director/PDMR Shareholding

GSK PLC 12 November 2024 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Emma Walmsley b) Position/status Chief...

GSK PLC GSK publishes provisional 2025 dividend dates

GSK PLC 11 November 2024 GSK plc GSK publishes provisional dividend dates GSK announces the following dividend dates for 2025: These dates are indicative and may be subject to...

GSK PLC Director/PDMR Shareholding

GSK PLC 19 November 2024 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Dr Hal Barron b) Position/status...

GSK hails positive results for linerixibat in treating relentless itch

GSK PLC on Tuesday said that its investigational targeted inhibitor linerixibat demonstrated sound results for a trea ...

GSK PLC GLISTEN Trial of Linerixibat Meets Endpoint

GSK PLC 19 November 2024 Issued: 19 November 2024, London UK Linerixibat shows positive Phase III results in cholestatic pruritus (relentless itch) in primary biliary cholangitis (PBC...

GSK hails survival results in blood cancer patients with Blenrep

GSK PLC on Thursday said its Blenrep drug has shown overall survival benefits in patients with relapsed or refractory ...

GSK PLC GSK announces overall survival results for Blenrep

GSK PLC 14 November 2024 Issued: 14 November 2024, London UK Blenrep shows overall survival benefit in head-to-head DREAMM-7 phase III trial for relapsed/refractory multiple myeloma · ...

GSK PLC Block listing Interim Review

GSK PLC 13 November 2024 BLOCK LISTING SIX MONTHLY RETURN Date: 13 November 2024 Name of applicant: GSK plc Name of scheme: GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan...

GSK PLC Director/PDMR Shareholding

GSK PLC 12 November 2024 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Emma Walmsley b) Position/status Chief...

GSK PLC GSK publishes provisional 2025 dividend dates

GSK PLC 11 November 2024 GSK plc GSK publishes provisional dividend dates GSK announces the following dividend dates for 2025: These dates are indicative and may be subject to...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-48.5	-3.58330254895	1353.5	1364.5	1282.5	12275192	1310.61943585	DE
4	-152.5	-10.4631217839	1457.5	1462.5	1282.5	10283630	1375.12499315	DE
12	-357.5	-21.5037593985	1662.5	1678	1282.5	8420977	1477.38240893	DE
26	-465	-26.2711864407	1770	1808.5	1282.5	8000386	1536.01672936	DE
52	-96.4	-6.87883545026	1401.4	1820	1282.5	7832674	1568.67366198	DE
156	-223	-14.5942408377	1528	1824.4	1282.5	8633412	1532.31011271	DE
260	-404.6	-23.6663547029	1709.6	1857	1190.8	8812893	1514.18037867	DE

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
RCGHRc365 Holding Plc	1.55p (24.00%)	1.54M
FARFerro-alloy Resources Limited	2.90p (23.40%)	3.77M
CRTMCritical Metals Plc	1.20p (20.00%)	493
RRRRed Rock Resources Plc	0.05p (11.11%)	21.55M
STXShield Therapeutics Plc	2.95p (10.28%)	14.45M
NTOGNostra Terra Oil And Gas Company Plc	0.024p (-36.00%)	374.6M
SLFRSlf Realisation Fund Limited	1.02p (-27.66%)	6.78k
PPSProton Motor Power Systems Plc	0.14p (-22.22%)	817.46k
QUIZQuiz Plc	4.12p (-21.52%)	8.54k
JANJangada Mines Plc	0.75p (-21.05%)	1.5M
NTOGNostra Terra Oil And Gas Company Plc	0.024p (-36.00%)	374.6M
NTVONativo Resources Plc	0.0023p (0.00%)	232.35M
TRPTower Resources Plc	0.027p (-1.82%)	89.03M
UKOGUk Oil & Gas Plc	0.02475p (0.00%)	33.15M
MSMNMosman Oil And Gas Limited	0.0395p (-1.25%)	32.38M